Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
8	13	Search

2025	Randomized Controlled Trial Assessing the Efficacy and Safety of a Liposomal Carrier for Low-Dose Dual Antiplatelet Therapy (Clopidogrel and Aspirin) in Coronary Heart Disease Patients Clinical Therapeutics Lu Yang, Jiaqi Mei, Fang Qiao, Shiyao Chen, Congcong Xu
2025	Exosomal ALKBH5 Alleviates Vascular Calcification by Suppressing Cell Apoptosis via m6A‐Modified GSDME Drug Development Research Guian Xu, Qingman Li, Lijie Zhu, Tingjie Yang, Yapan Yang, Honghui Yang
2025	The N6-methyladenosine demethylase ALKBH5 is a novel epigenetic regulator of aortic valve calcification Cardiovascular Research Yueheng Wang, Shengping He, Lan Lan, Hongjiao Yu, Huan Zhao, Yuchen Xie, Guoli Zhong, Liang Yuan, Kun Li, Xiao Hu, Vicky E Macrae, Xiaodong Fu, Guojun Chen, Dongxing Zhu
2025	A comprehensive review of m6 A methylation in coronary heart disease Journal of Molecular Medicine Mei-Ning Diao, Yi-Jv Lv, Hui Xin, Yin-Feng Zhang, Rui Zhang
2025	ALKBH5 Regulates Inflammation and Pyroptosis of Coronary Heart Disease by Targeting SPEN in a YTHDF1-Mediated Manner Cardiovascular Drugs and Therapy Shan Huang, Jizhang Huang, Yongguang Lu, Zewen Hong, Guoyong Lai, Yunyu Chen
2024	ALKBH5‐mediated m6A demethylation of pri‐miR‐199a‐5p exacerbates myocardial ischemia/reperfusion injury by regulating TRAF3‐mediated pyroptosis Journal of Biochemical and Molecular Toxicology Jiarong Li, Zhirong Wang, Huayi Tan, Mi Tang
2024	ALKBH5 Protects Against Hepatic Ischemia–Reperfusion Injury by Regulating YTHDF1-Mediated YAP Expression International Journal of Molecular Sciences Pixiao Wang, Mei Xiang, Ling Zhu, Rixin Zhang, Xiaolin Zheng, Zhi Zheng, Kai Li
2024	The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis Frontiers in Cell and Developmental Biology Ziwei Liao, Jing Wang, Mengrou Xu, Xiaoyan Li, Hongming Xu
	Additional cited-by details will be shown when available from Crossref